Cryo-Cell International, Inc. Stock Other OTC
Equities
CCEL
US2288951088
Healthcare Facilities & Services
Financials (USD)
Sales 2024 * | 31.78M | Sales 2025 * | 35.21M | Capitalization | 72.37M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 1M | EV / Sales 2024 * | 2.28 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.06 x |
P/E ratio 2024 * |
298
x | P/E ratio 2025 * |
74.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.32% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Portnoy
CEO | Chief Executive Officer | 60 | 11-07-31 |
David Portnoy
CEO | Chief Executive Officer | 61 | 11-07-31 |
Jill Taymans
DFI | Director of Finance/CFO | 55 | 97-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Portnoy
CEO | Chief Executive Officer | 61 | 11-07-31 |
Mark Portnoy
CEO | Chief Executive Officer | 60 | 11-07-31 |
Harold Berger
BRD | Director/Board Member | 60 | 11-08-24 |
1st Jan change | Capi. | |
---|---|---|
+13.70% | 81.4B | |
-29.20% | 70.18B | |
+9.72% | 29.08B | |
-11.43% | 16.97B | |
-0.43% | 16.96B | |
-0.31% | 15.26B | |
+3.42% | 12.41B | |
-30.70% | 11.95B | |
-6.75% | 11.93B |